Literature DB >> 24006434

Aluminum hydroxide influences not only the extent but also the fine specificity and functional activity of antibody responses to tick-borne encephalitis virus in mice.

Juergen Zlatkovic1, Georgios Tsouchnikas, Johanna Jarmer, Christian Koessl, Karin Stiasny, Franz X Heinz.   

Abstract

Aluminum hydroxide is the most widely used adjuvant in human vaccines and serves as a potent enhancer of antibody production. Its stimulatory effect strongly depends on the adsorption of the antigen to the adjuvant, which may influence antigen presentation and, as a consequence, the fine specificity of antibody responses. Such variations can have functional consequences and can modulate the effectiveness of humoral immunity. Therefore, we investigated the influence of aluminum hydroxide on the fine specificity of antibody responses in a model study in mice using an inactivated purified virus particle, the flavivirus tick-borne encephalitis (TBE) virus, as an immunogen. To dissect and quantify the specificities of polyclonal antibodies in postimmunization sera, we established a platform of immunoassays using recombinant forms of the major target of neutralizing antibodies (protein E) as well as individual domains of E (DIII and the combination of DI and DII [DI+DII]). Our analyses revealed a higher proportion of neutralizing than virion binding (as detected by enzyme-linked immunosorbent assay) antibodies after immunization with aluminum hydroxide. Furthermore, the induction of antibodies to DIII, a known target of potently neutralizing antibodies, as well as their contributions to virus neutralization were significantly greater in mice immunized with adjuvant and correlated with a higher avidity of these antibodies. Thus, our data provide evidence that aluminum hydroxide can lead to functionally relevant modulations of antibody fine specificities in addition to its known overall immune enhancement effect.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24006434      PMCID: PMC3807910          DOI: 10.1128/JVI.01690-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Structure of dengue virus: implications for flavivirus organization, maturation, and fusion.

Authors:  Richard J Kuhn; Wei Zhang; Michael G Rossmann; Sergei V Pletnev; Jeroen Corver; Edith Lenches; Christopher T Jones; Suchetana Mukhopadhyay; Paul R Chipman; Ellen G Strauss; Timothy S Baker; James H Strauss
Journal:  Cell       Date:  2002-03-08       Impact factor: 41.582

2.  Aluminum compounds as vaccine adjuvants.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-07-06       Impact factor: 15.470

3.  Structure of West Nile virus.

Authors:  Suchetana Mukhopadhyay; Bong-Suk Kim; Paul R Chipman; Michael G Rossmann; Richard J Kuhn
Journal:  Science       Date:  2003-10-10       Impact factor: 47.728

4.  Effect of phosphorylation of ovalbumin on adsorption by aluminum-containing adjuvants and elution upon exposure to interstitial fluid.

Authors:  Garry L Morefield; Dongping Jiang; Ilia Z Romero-Mendez; Robert L Geahlen; Harm Hogenesch; Stanley L Hem
Journal:  Vaccine       Date:  2005-02-10       Impact factor: 3.641

5.  Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome.

Authors:  Mirjam Kool; Virginie Pétrilli; Thibaut De Smedt; Aline Rolaz; Hamida Hammad; Menno van Nimwegen; Ingrid M Bergen; Rosa Castillo; Bart N Lambrecht; Jürg Tschopp
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

6.  Antibodies protect mice against challenge with tick-borne encephalitis virus (TBEV)-infected macrophages.

Authors:  T R Kreil; I Burger; M Bachmann; S Fraiss; M M Eibl
Journal:  Clin Exp Immunol       Date:  1997-12       Impact factor: 4.330

7.  The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution.

Authors:  F A Rey; F X Heinz; C Mandl; C Kunz; S C Harrison
Journal:  Nature       Date:  1995-05-25       Impact factor: 49.962

8.  Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens.

Authors:  LaToya S Jones; Laura J Peek; Jonathan Power; Aaron Markham; Brian Yazzie; C Russell Middaugh
Journal:  J Biol Chem       Date:  2005-01-31       Impact factor: 5.157

9.  Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses.

Authors:  J L Grun; P H Maurer
Journal:  Cell Immunol       Date:  1989-06       Impact factor: 4.868

10.  Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites.

Authors:  Karin Stiasny; Stefan Kiermayr; Heidemarie Holzmann; Franz X Heinz
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

View more
  13 in total

1.  Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope prediction.

Authors:  Julia Schwaiger; Judith H Aberle; Karin Stiasny; Bernhard Knapp; Wolfgang Schreiner; Ingrid Fae; Gottfried Fischer; Ondrej Scheinost; Vaclav Chmelik; Franz X Heinz
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

2.  Immunization with Immune Complexes Modulates the Fine Specificity of Antibody Responses to a Flavivirus Antigen.

Authors:  Georgios Tsouchnikas; Juergen Zlatkovic; Johanna Jarmer; Judith Strauß; Oksana Vratskikh; Michael Kundi; Karin Stiasny; Franz X Heinz
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

3.  Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination.

Authors:  Johanna Jarmer; Jürgen Zlatkovic; Georgios Tsouchnikas; Oksana Vratskikh; Judith Strauß; Judith H Aberle; Vaclav Chmelik; Michael Kundi; Karin Stiasny; Franz X Heinz
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

4.  The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm.

Authors:  Tirth Raj Ghimire
Journal:  Springerplus       Date:  2015-04-16

5.  A novel mechanism of antibody-mediated enhancement of flavivirus infection.

Authors:  Denise Haslwanter; Dieter Blaas; Franz X Heinz; Karin Stiasny
Journal:  PLoS Pathog       Date:  2017-09-15       Impact factor: 6.823

6.  Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy.

Authors:  Wanbo Tai; Jiawei Chen; Yusen Zhou; Fang Li; Lanying Du; Guangyu Zhao; Qibin Geng; Lei He; Yuehong Chen
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

7.  Evervac: phase I/II study of immunogenicity and safety of a new adjuvant-free TBE vaccine cultivated in Vero cell culture.

Authors:  Mikhail F Vorovitch; Karina G Grishina; Viktor P Volok; Liubov L Chernokhaeva; Konstantin V Grishin; Galina G Karganova; Aidar A Ishmukhametov
Journal:  Hum Vaccin Immunother       Date:  2020-05-19       Impact factor: 3.452

8.  In Vitro Characterization of the Innate Immune Pathways Engaged by Live and Inactivated Tick-Borne Encephalitis Virus.

Authors:  Aurora Signorazzi; Jeroen L A Pennings; Marilena P Etna; Malou Noya; Eliana M Coccia; Anke Huckriede
Journal:  Vaccines (Basel)       Date:  2021-06-17

Review 9.  Current challenges facing the assessment of the allergenic capacity of food allergens in animal models.

Authors:  Katrine Lindholm Bøgh; Jolanda van Bilsen; Robert Głogowski; Iván López-Expósito; Grégory Bouchaud; Carine Blanchard; Marie Bodinier; Joost Smit; Raymond Pieters; Shanna Bastiaan-Net; Nicole de Wit; Eva Untersmayr; Karine Adel-Patient; Leon Knippels; Michelle M Epstein; Mario Noti; Unni Cecilie Nygaard; Ian Kimber; Kitty Verhoeckx; Liam O'Mahony
Journal:  Clin Transl Allergy       Date:  2016-06-16       Impact factor: 5.871

Review 10.  Aluminium toxicosis: a review of toxic actions and effects.

Authors:  Ikechukwu Onyebuchi Igbokwe; Ephraim Igwenagu; Nanacha Afifi Igbokwe
Journal:  Interdiscip Toxicol       Date:  2020-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.